Investors are optimistic about Globus Medical (GMED) led by strong musculoskeletal prospects and raised guidance.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Exact Sciences (EXAS) has numerous competitors, given the large market for colorectal cancer screening.